Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China · Delayed Price · Currency is CNY 44.65
-1.88 (-4.04%)
Sep 11, 2026, 3:00 PM CST
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 8.08 billion as of September 11, 2026. Its market cap has decreased by -14.11% in one year.
Market Cap
8.08B
Enterprise Value
6.64B
Revenue
1.34B
Ranking
n/a
PE Ratio
29.08
Stock Price
44.65
ChartMarket Cap Chart
Since September 2, 2020, SHA:688513's market cap has decreased from 8.97B to 8.08B, a decrease of -10.00%. That is a compound annual growth rate of -1.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 7.75B | -27.78% |
| Dec 31, 2025 | 10.73B | 104.34% |
| Dec 31, 2024 | 5.25B | -31.43% |
| Dec 29, 2023 | 7.66B | 4.83% |
| Dec 30, 2022 | 7.31B | 31.12% |
| Dec 31, 2021 | 5.57B | -2.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shanghai OPM Biosciences | 9.31B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 9.09B |
| Liaoning Chengda Biotechnology | 8.36B |
| Vcanbio Cell & Gene Engineering Corp., | 8.22B |
| Chongqing Genrix Biopharmaceutical | 8.20B |
| Aurisco Pharmaceutical | 7.75B |
| Beijing Hotgen Biotech | 7.72B |
| Daan Gene | 7.59B |